Drug Shortage Report for MAXIDEX

Last updated on 2019-02-05 History
Report ID 59391
Drug Identification Number 00042579
Brand name MAXIDEX
Common or Proper name MAXIDEX OINTMENT 3.5MG
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) DEXAMETHASONE
Strength(s) 0.1%
Dosage form(s) OINTMENT
Route of administration OPHTHALMIC
Packaging size 3.5MG
ATC code S01BA
ATC description ANTIINFLAMMATORY AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-09-10
Actual start date 2018-09-10
Estimated end date 2019-02-04
Actual end date 2019-02-04
Shortage status Resolved
Updated date 2019-02-05
Company comments Maxidex 0.1% Suspension 5ml is available (#742021)
Health Canada comments
Tier 3 Status No
Contact Address 700 RUE SAINT-HUBERT
MONTREAL, QUEBEC
CANADA H2Y 0C1
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-08-28 English Compare
v2 2018-08-28 French Compare
v3 2018-09-11 English Compare
v4 2018-09-26 English Compare
v5 2018-09-26 French Compare
v6 2018-10-05 English Compare
v7 2018-10-05 English Compare
v8 2018-10-05 English Compare
v9 2018-10-05 French Compare
v10 2018-10-05 English Compare
v11 2018-10-05 English Compare
v12 2018-10-05 French Compare
v13 2018-10-17 English Compare
v14 2018-10-17 French Compare
v15 2018-10-23 English Compare
v16 2018-10-23 French Compare
v17 2018-11-01 English Compare
v18 2018-11-01 French Compare
v19 2018-11-16 English Compare
v20 2018-11-16 French Compare

Showing 1 to 20 of 33